Please use this identifier to cite or link to this item:
https://hdl.handle.net/11499/36990
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Gürbüz, N. | - |
dc.contributor.author | Kaloğlu, N. | - |
dc.contributor.author | Kızrak, Ü. | - |
dc.contributor.author | Özdemir, İsmail | - |
dc.contributor.author | Türkmen, N.B. | - |
dc.contributor.author | Çiftçi, Osman | - |
dc.contributor.author | Mansour, L. | - |
dc.date.accessioned | 2021-02-02T09:23:31Z | |
dc.date.available | 2021-02-02T09:23:31Z | |
dc.date.issued | 2020 | - |
dc.identifier.issn | 0022-328X | - |
dc.identifier.uri | https://hdl.handle.net/11499/36990 | - |
dc.identifier.uri | https://doi.org/10.1016/j.jorganchem.2020.121434 | - |
dc.description.abstract | In this study, sulfonate functionalized N-heterocyclic carbene ligand precursors were obtained from the compounds 1-alkylbenzimidazole, 1,3-propane sultone, and 1,4-butane sultone. These NHC ligand precursors were metallated with Ag2O on moderate conditions to give novel silver-NHC complexes. All new compounds were characterized by by 1H NMR, 13C NMR, FT-IR and elemental analysis techniques. The cytotoxic properties of the silver(I) complexes have been assessed in various human cancer lines, including cisplatin-sensitive and resistant cells. IC50 values of these four complexes were determined by the MTT based assay on three human cell lines brain (SHSY5Y) and liver (HEP3B). These silver N-heterocyclic carbene complexes have been highlighted metal-based cancer therapeutic agents with unique structures and functions. These strategies provide exciting opportunities for discovering new types of metallodrugs. © 2020 Elsevier B.V. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Elsevier B.V. | en_US |
dc.relation.ispartof | Journal of Organometallic Chemistry | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Antitumor activity | en_US |
dc.subject | Benzimidazolium salts | en_US |
dc.subject | N-heterocyclic carbene | en_US |
dc.subject | Silver-NHC complexes | en_US |
dc.subject | Sultone | en_US |
dc.subject | Cell culture | en_US |
dc.subject | Diseases | en_US |
dc.subject | Ligands | en_US |
dc.subject | Organic compounds | en_US |
dc.subject | Silver oxides | en_US |
dc.subject | 1 ,3-propane sultone | en_US |
dc.subject | Analysis techniques | en_US |
dc.subject | Functionalized N-heterocyclic carbene | en_US |
dc.subject | Human cell lines | en_US |
dc.subject | N-heterocyclic carbene complex | en_US |
dc.subject | Resistant cells | en_US |
dc.subject | Silver complexes | en_US |
dc.subject | Therapeutic agents | en_US |
dc.subject | Synthesis (chemical) | en_US |
dc.title | Silver(I) N-heterocyclic carbene complexes: Synthesis, characterization and cytotoxic properties | en_US |
dc.type | Article | en_US |
dc.identifier.volume | 923 | en_US |
dc.authorid | 0000-0001-5755-3560 | - |
dc.authorid | 0000-0001-6325-0216 | - |
dc.identifier.doi | 10.1016/j.jorganchem.2020.121434 | - |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.identifier.scopus | 2-s2.0-85088927383 | en_US |
dc.identifier.wos | WOS:000575167700004 | en_US |
dc.identifier.scopusquality | Q2 | - |
dc.owner | Pamukkale University | - |
item.languageiso639-1 | en | - |
item.fulltext | No Fulltext | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.cerifentitytype | Publications | - |
item.openairetype | Article | - |
item.grantfulltext | none | - |
crisitem.author.dept | 14.02. Internal Medicine | - |
Appears in Collections: | Fen-Edebiyat Fakültesi Koleksiyonu Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection Tıp Fakültesi Koleksiyonu WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection |
CORE Recommender
SCOPUSTM
Citations
7
checked on Oct 13, 2024
WEB OF SCIENCETM
Citations
6
checked on Nov 21, 2024
Page view(s)
64
checked on Aug 24, 2024
Google ScholarTM
Check
Altmetric
Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.